فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

novartis finland oy - terbinafini hydrochloridum - tabletti - 250 mg - terbinafiini

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

orion corporation - terbinafine hydrochloride - tabletti - 250 mg - terbinafiini

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

polichem sa - ciclopirox - lääkekynsilakka - 80 mg/g - siklopiroksi

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belantamab mafodotin - multiple myeloma - antineoplastiset aineet - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiset aineet - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

astrazeneca oy - happo ascorbicum,natrii percarbonas,kupari sulfas anhydricus - solubletti - muut

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

astra alab ab - happo ascorbicum,kupari sulfas anhydricus,natrii percarbonas - purutabletti - muut

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

schering oy - cobaltosi chloridum,kupari sulfas,magnesiumia chloridum - liuos - asetonemian hoitoon ja/tai ennaltaehkäisyyn tarkoitetut lääkkeet